Aquatic Capital Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-24,103
Closed -$635K 1873
2025
Q4
$635K Buy
+24,103
New +$526K 0.02% 676
2025
Q2
Sell
-2,049
Closed -$24.4K 1601
2025
Q1
$24.4K Buy
+2,049
New +$27.9K ﹤0.01% 1172
2022
Q2
Sell
-800
Closed -$5K 1622
2022
Q1
$5K Sell
800
-2,300
-74% -$20.5K 0.01% 838
2021
Q4
$51K Buy
+3,100
New +$64.6K 0.1% 306

Other funds holding ZYME

Aquatic Capital Management's ZYME Position: Q1 2026 in Review

Aquatic Capital Management sold out of Zymeworks (ZYME) in Q1 2026, closing a stake of 24,103 shares — an estimated $635K sold.

Aquatic Capital Management first reported a position in ZYME in Q4 2021 and held it in 4 quarters. The position peaked at $635K in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Aquatic Capital Management reported no remaining Zymeworks position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 24,103 Zymeworks shares in Q1 2026, an estimated $635K.
  • Aquatic Capital Management first reported a position in Zymeworks in Q4 2021 and held it in 4 quarters.
  • Aquatic Capital Management's Zymeworks position peaked at $635K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.